Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
SEC Accession No. 0001013594-09-001008
Filing Date
2009-05-12
Accepted
2009-05-12 13:43:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 MAY 12, 2009 enzonprrn14a-051209.htm PRRN14A 251349
  Complete submission text file 0001013594-09-001008.txt   253589
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRRN14A | Act: 34 | File No.: 000-12957 | Film No.: 09818086
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 461 FIFTH AVENUE 10TH FLOOR NEW YORK NY 10017
Business Address 461 FIFTH AVENUE 10TH FLOOR NEW YORK NY 10017 (212) 808-3590
DellaCamera Capital Management, LLC (Filed by) CIK: 0001391052 (see all company filings)

EIN.: 061757281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRRN14A